Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors

Summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines

Susan M. Chang, Hans Messersmith, Manmeet Ahluwalia, David Andrews, Priscilla K. Brastianos, Laurie E. Gaspar, Na Tosha N. Gatson, Justin T. Jordan, Mustafa Khasraw, Andrew B. Lassman, Julia Maues, Maciej Mrugala, Jeffrey Raizer, David Schiff, Glen Stevens, Ashley Sumrall, Martin Van Den Bent, Michael A. Vogelbaum

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background. The Congress of Neurological Surgeons (CNS) has developed a series of guidelines on the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. Methods. Two CNS Guidelines were reviewed for developmental rigor by methodologists and an independent multi-disciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The expert panel voted to endorse the two guidelines and ASCO and SNO independently reviewed and approved the ASCO/SNO guideline endorsement. Results. The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based upon the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines, with minor alterations. Conclusions. Key recommendations include: prophylactic anti-epileptic drugs were not recommended for routine use; corticosteroids (specifically dexamethasone) were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases.

Original languageEnglish (US)
Pages (from-to)424-427
Number of pages4
JournalNeuro-oncology
Volume21
Issue number4
DOIs
StatePublished - Mar 18 2019

Fingerprint

Brain Neoplasms
Anticonvulsants
Steroids
Guidelines
Neurologic Manifestations
Practice Guidelines
Dexamethasone
Adrenal Cortex Hormones
Neoplasm Metastasis
Brain
Therapeutics
Pharmaceutical Preparations
Neurosurgeons

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors : Summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines. / Chang, Susan M.; Messersmith, Hans; Ahluwalia, Manmeet; Andrews, David; Brastianos, Priscilla K.; Gaspar, Laurie E.; Gatson, Na Tosha N.; Jordan, Justin T.; Khasraw, Mustafa; Lassman, Andrew B.; Maues, Julia; Mrugala, Maciej; Raizer, Jeffrey; Schiff, David; Stevens, Glen; Sumrall, Ashley; Van Den Bent, Martin; Vogelbaum, Michael A.

In: Neuro-oncology, Vol. 21, No. 4, 18.03.2019, p. 424-427.

Research output: Contribution to journalArticle

Chang, SM, Messersmith, H, Ahluwalia, M, Andrews, D, Brastianos, PK, Gaspar, LE, Gatson, NTN, Jordan, JT, Khasraw, M, Lassman, AB, Maues, J, Mrugala, M, Raizer, J, Schiff, D, Stevens, G, Sumrall, A, Van Den Bent, M & Vogelbaum, MA 2019, 'Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: Summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines', Neuro-oncology, vol. 21, no. 4, pp. 424-427. https://doi.org/10.1093/neuonc/noz034
Chang, Susan M. ; Messersmith, Hans ; Ahluwalia, Manmeet ; Andrews, David ; Brastianos, Priscilla K. ; Gaspar, Laurie E. ; Gatson, Na Tosha N. ; Jordan, Justin T. ; Khasraw, Mustafa ; Lassman, Andrew B. ; Maues, Julia ; Mrugala, Maciej ; Raizer, Jeffrey ; Schiff, David ; Stevens, Glen ; Sumrall, Ashley ; Van Den Bent, Martin ; Vogelbaum, Michael A. / Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors : Summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines. In: Neuro-oncology. 2019 ; Vol. 21, No. 4. pp. 424-427.
@article{96d79d963f2840eb90a0551dee225962,
title = "Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: Summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines",
abstract = "Background. The Congress of Neurological Surgeons (CNS) has developed a series of guidelines on the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. Methods. Two CNS Guidelines were reviewed for developmental rigor by methodologists and an independent multi-disciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The expert panel voted to endorse the two guidelines and ASCO and SNO independently reviewed and approved the ASCO/SNO guideline endorsement. Results. The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based upon the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines, with minor alterations. Conclusions. Key recommendations include: prophylactic anti-epileptic drugs were not recommended for routine use; corticosteroids (specifically dexamethasone) were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases.",
author = "Chang, {Susan M.} and Hans Messersmith and Manmeet Ahluwalia and David Andrews and Brastianos, {Priscilla K.} and Gaspar, {Laurie E.} and Gatson, {Na Tosha N.} and Jordan, {Justin T.} and Mustafa Khasraw and Lassman, {Andrew B.} and Julia Maues and Maciej Mrugala and Jeffrey Raizer and David Schiff and Glen Stevens and Ashley Sumrall and {Van Den Bent}, Martin and Vogelbaum, {Michael A.}",
year = "2019",
month = "3",
day = "18",
doi = "10.1093/neuonc/noz034",
language = "English (US)",
volume = "21",
pages = "424--427",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors

T2 - Summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines

AU - Chang, Susan M.

AU - Messersmith, Hans

AU - Ahluwalia, Manmeet

AU - Andrews, David

AU - Brastianos, Priscilla K.

AU - Gaspar, Laurie E.

AU - Gatson, Na Tosha N.

AU - Jordan, Justin T.

AU - Khasraw, Mustafa

AU - Lassman, Andrew B.

AU - Maues, Julia

AU - Mrugala, Maciej

AU - Raizer, Jeffrey

AU - Schiff, David

AU - Stevens, Glen

AU - Sumrall, Ashley

AU - Van Den Bent, Martin

AU - Vogelbaum, Michael A.

PY - 2019/3/18

Y1 - 2019/3/18

N2 - Background. The Congress of Neurological Surgeons (CNS) has developed a series of guidelines on the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. Methods. Two CNS Guidelines were reviewed for developmental rigor by methodologists and an independent multi-disciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The expert panel voted to endorse the two guidelines and ASCO and SNO independently reviewed and approved the ASCO/SNO guideline endorsement. Results. The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based upon the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines, with minor alterations. Conclusions. Key recommendations include: prophylactic anti-epileptic drugs were not recommended for routine use; corticosteroids (specifically dexamethasone) were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases.

AB - Background. The Congress of Neurological Surgeons (CNS) has developed a series of guidelines on the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. Methods. Two CNS Guidelines were reviewed for developmental rigor by methodologists and an independent multi-disciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The expert panel voted to endorse the two guidelines and ASCO and SNO independently reviewed and approved the ASCO/SNO guideline endorsement. Results. The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based upon the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines, with minor alterations. Conclusions. Key recommendations include: prophylactic anti-epileptic drugs were not recommended for routine use; corticosteroids (specifically dexamethasone) were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases.

UR - http://www.scopus.com/inward/record.url?scp=85063263024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063263024&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noz034

DO - 10.1093/neuonc/noz034

M3 - Article

VL - 21

SP - 424

EP - 427

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 4

ER -